WHO Backs Pfizer's Oral COVID Therapy for High-Risk Patients



The World Health Organization (WHO) on Thursday endorsed the use of Pfizer Inc's oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data by the U.N. agency showed the therapy dramatically cut the risk of hospitalization. More treatment, more safety!


Read more about it


Photo Credit: Pawel Czerwinski

0 views0 comments